Explore Products
Tumor Cell Lines

QGP-1

  • BSL

    1

  • 582
Human pancreatic islet cell carcinoma cell line with carcinoembryonic antigen (CEA)-positive. This cell line secretes somatostatin, but not RI and RI B, suggesting that this cell line originates from islet D-cells.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

QGP 1; QGP1

Species

Human

Cat.No

ABC-TC0918

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Epithelial-like

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Pancreas

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Pancreas Cancer Cell Lines

Description

QGP-1QGP-1 is a human pancreatic neuroendocrine tumor cell line derived from the pancreas of a male patient with a carcinoid tumor. These epithelial-like cells are polygonal or rounded and grow adherently in standard culture conditions (37°C, 5% CO₂). The cell line expresses neuroendocrine markers such as carcinoembryonic antigen (CEA) and synaptophysin, and shows elevated expression of transcription factors related to neuroendocrine differentiation, immature pancreatic β/δ-cell genes. The cell line exhibits genomic instability, with a portion of the cells showing a tetraploid karyotype. This cell line also exhibits the expression of somatostatin receptors (SSTR2 and SSTR5), making it an important in vitro model for studying pancreatic neuroendocrine tumors (pNETs).

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Si, Y., Kim, S., Guenter, R., Ou, J., Lu, Y., Chen, K., Zhang, J., Whitt, J., Carter, A.M., Bibb, J.A. and Jaskula-Sztul, R., 2019. Anti-SSTR2 Antibody-Drug Conjugate for Neuroendocrine Cancer Therapy. bioRxiv, p.688184.
Si, Y., Guan, J., Xu, Y., Chen, K., Kim, S., Zhou, L., Jaskula-Sztul, R. and Liu, X.M., 2020. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics, 12(11), p.1079.
Herring, B., Jang, S., Whitt, J., Goliwas, K., Aburjania, Z., Dudeja, V., Ren, B., Berry, J., Bibb, J., Frost, A. and Chen, H., 2021. Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates. Frontiers in endocrinology, 12.

Application

  • QGP-1 cell line can serve as an in vitro cell model for neuroendocrine tumor (NET) drug development. In addition, the QGP-1 cell line is also an excellent model for studying human enterochromaffin (EC) cells. Because it highly expresses EC cell marker genes and transient receptor potential ankyrin 1 (TRPA1), it can be used to further explore the function and regulatory mechanism of TRPA1 in EC cells.

Inquiring QGP-1

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button